1. Home
  2. JHG vs CRL Comparison

JHG vs CRL Comparison

Compare JHG & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janus Henderson Group plc

JHG

Janus Henderson Group plc

HOLD

Current Price

$51.41

Market Cap

7.9B

Sector

Finance

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$165.99

Market Cap

7.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JHG
CRL
Founded
1934
1947
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
7.5B
IPO Year
2003
1999

Fundamental Metrics

Financial Performance
Metric
JHG
CRL
Price
$51.41
$165.99
Analyst Decision
Hold
Buy
Analyst Count
8
13
Target Price
$47.38
$197.58
AVG Volume (30 Days)
3.6M
754.3K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
2.33%
N/A
EPS Growth
104.30
N/A
EPS
5.23
N/A
Revenue
$1,743,700,000.00
$1,857,601,000.00
Revenue This Year
N/A
$0.99
Revenue Next Year
$6.18
$3.26
P/E Ratio
$9.82
N/A
Revenue Growth
74.39
10.48
52 Week Low
$28.26
$91.86
52 Week High
$53.76
$228.88

Technical Indicators

Market Signals
Indicator
JHG
CRL
Relative Strength Index (RSI) 56.64 47.93
Support Level $50.02 $146.49
Resistance Level $53.76 $166.62
Average True Range (ATR) 0.63 6.68
MACD -0.06 1.45
Stochastic Oscillator 55.67 54.04

Price Performance

Historical Comparison
JHG
CRL

About JHG Janus Henderson Group plc

Janus Henderson Group provides investment management services to retail intermediary (50% of managed assets), self-directed (20%) and institutional (30%) clients. At the end of September 2025, active equities (52%), fixed-income (32%), balanced (12%) and alternative (4%) investment platforms constituted the company's $484 billion in assets under management. Janus Henderson sources most of its managed assets from clients in North America (67%), with customers from Europe, the Middle East, Africa, and Latin America (25%) and the Asia-Pacific region (8%) accounting for the remainder.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: